Robin Vacha - 01 Feb 2024 Form 4 Insider Report for Azenta, Inc. (AZTA)

Reporting relationship: SVP, GM Life Science Products
Issuer ticker: AZTA
Reported as of: 01 Feb 2024
Net transaction value: +$12,769
SEC form: 4
Accepted by SEC: 02 Feb 2024, 16:10:10 UTC
Prior SEC filing: 02 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/Jason W. Joseph, Attorney-in-fact for Robin Vacha

Key filing fact

Robin Vacha filed Form 4 for Azenta, Inc. (AZTA) on 02 Feb 2024.

Key facts

This page summarizes Robin Vacha's Form 4 filing for Azenta, Inc. (AZTA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Feb 2024, 16:10.

Change

Previous filing in this sequence was filed on 02 Aug 2024.
Current net transaction value: +$12,769.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AZTA transaction

Common

Award

Transaction value: $12,769
Shares: +324
Change %: +1%
Price: $39.41
Shares after: 31,287
Date: 01 Feb 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act